Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of ciprofol versus etomidate for anesthesia induction in cardiac surgery
ChiCTR2300074434Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Aug 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in Cardiac valve disease (VHD) and coronary arteriosclerosis (4 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Mean arterial pressure, Cardiac output and 6 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
Cardiac valve disease (VHD)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2300074434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074434.